[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III study to investigate the efficacy, safety, and tolerability of oral AK0901 capsules in children aged 6 to 12 years with attention deficit hyperactivity disorder
评估 AK0901 与安慰剂相比在 6~12 岁 ADHD 儿童受试者中的疗效。评估 AK0901 与安慰剂相比在 6~12 岁 ADHD 儿童受试者中的安全性和耐受性。
[Translation] To evaluate the efficacy of AK0901 compared with placebo in pediatric subjects aged 6-12 years with ADHD. To evaluate the safety and tolerability of AK0901 compared with placebo in pediatric subjects aged 6-12 years with ADHD.